Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways

Toxicology and Applied Pharmacology

Volumn 141, Issue 1, 1996, Pages 238-247

  Hoffer, Amy ^a   Chang, Ching Yi ^a   Puga, Alvaro ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; DIOXIN; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL CELL; ARTICLE; CELL CULTURE; CERCOPITHECIDAE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE ACTIVATION; GENE CONSTRUCT; GENE EXPRESSION; HEPATOMA CELL; IN VITRO STUDY; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C FOS; PROTO ONCOGENE; SIGNAL TRANSDUCTION; TOXICITY;

ANIMALIA; CERCOPITHECIDAE; CERCOPITHECUS AETHIOPS;

EID: 0030296584     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0280     Document Type: Article

References (75)

1. Aronheim, A., Engelberg, D., Li, N., Al-Alawi, N., Schlessinger, J., and Karin, M. (1994). Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway. Cell 78, 949-961.
2. Baker, T. K., Kwiatkowski, A. P., Madhukar, B. V., and Klaunig, J. E. (1995). Inhibition of gap junctional intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat hepatocytes. Carcinogenesis 16, 2321-2326.
3. Beebe, L., Park, S. S., and Andersen, L. M. (1990). Differential enzyme induction of mouse liver and lung following a single low or high dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J. Biochem. Toxicol. 5, 211-219.
4. Bernard, H. P., Darlington, G. J., and Ruddle, F. H. (1973). Expression of liver phenotypes in cultured mouse hepatoma cells: Synthesis and secretion of serum albumin. Dev. Biol. 35, 83-96.
5. Binetruy, B., Smeal, T., and Karin, M. (1991). Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351, 122-127.
6. Bombick, D. W., Matsumura, F., and Madhukar, B. V. (1984). TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes reduction in the low density lipoprotein (LDL) receptor activities in the hepatic plasma membrane of the guinea pig and rat. Biochem. Biophys. Res. Commun. 118, 548-554.
7. Bombick, D. W., Madhukar, B. V., Brewster, D. W., and Matsumura, F. (1985). TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes increases in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and the guinea pig. Biochem. Biophys. Res. Commun. 127, 296-302.
8. Bombick, D. W., Jankun, J., Tullis, K., and Matsumura, F. (1988). 2,3,7,8-tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains. Proc. Natl. Acad. Sci. USA 85, 4128-4132.
9. Burbach, K. M., Poland, A., and Bradfield, C. A. (1992). Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. USA 89, 8185-8189.
10. Carrier, F., Owens, R. A., Nebert, D. W., and Puga, A. (1992). Dioxin-dependent activation of murine Cyp1a-1 transcription requires protein kinase C-dependent phosphorylation. Mol. Cell. Biol. 12, 1856-1863.
11. Carrier, F., Chang, C.-Y., Duh, J.-L., Nebert, D. W., and Puga, A. (1994). Interaction of the regulatory domains of the murine Cyp1a1 gene with two DNA binding proteins in addition to the Ah receptor and the Ah receptor nuclear translocator (ARNT). Biochem. Pharmacol. 48, 1767-1778.
12. De Haan, L. H., Simons, J. W., Bos, A. T., Aarts, J. M., Denison, M. S., and Brouwer, A. (1994). Inhibition of intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like PCBs in mouse hepatoma cells (Hepa1c1c7): Involvement of the Ah receptor. Toxicol. Appl. Pharmacol. 129, 283-293.
13. Deng, T., and Karin, M. (1994). c-Fos transcriptional activity stimulated by H-ras-activated protein kinase distinct from JNK and ERK. Nature 371, 171-175.
14. Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994). JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
15. Devary, Y., Gottlieb, R. A., Smeal, T., and Karin, M. (1992). The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71, 1081-1091.
16. DeVito, M. J., Ma, X., Babish, J. G., Menache, M., and Birnbaum, L. S. (1994). Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation. Toxicol. Appl. Pharmacol. 124, 82-90.
17. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
18. Ebner, K., Matsumura, F., Enan, E., and Olsen, H. (1993). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters pancreatic membrane tyrosine phosphorylation following acute treatment. J. Biochem. Toxicol. 8, 71-81.
19. Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., Funae, Y., and Fujii-Kuriyama, Y. (1992). cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184, 246-253.
20. Enan, E., and Matsumura, F. (1994). Significance of TCDD-induced changes in protein phosphorylation in the adipocyte of male guinea pigs. J. Biochem. Toxicol. 9, 159-170.
21. Enan, E., and Matsumura, F. (1995). Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochem. Pharmacol. 49, 249-261.
22. Engelberg, D., Klein, C., Martinetto, H., Struhl, K., and Karin, M. (1994). The UV response involving the ras signaling pathway and AP-1 transcription factors is conserved between yeast and mammals. Cell 77, 381-390.
23. Fingerhut, M. A., Halperin, W. E., Marlow, D. A., Piacitelli, L. A., Honchar, P. A., Sweeney, M. H., Greife, A. L., Dill, P. A., Steenland, K., and Suruda, A. J. (1991). Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin [see comments]. N. Engl. J. Med. 324, 212-218.
24. Flesch-Janys, D., Berger, J., Gurn, P., Manz, A., Nagel, S., Waltsgott, H., and Dwyer, J. H. (1995). Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am. J. Epidemiol. 142, 1165-1175.
25. Flodström, S., Busk, L., Kronevi, T., and Ahlborg, U. G. (1991). Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital-induced promotion of hepatocarcinogenesis in rats by the type of diet and vitamin A deficiency. Fundam. Appl. Toxicol. 16, 375-391.
26. Fukunaga, B. N., Probst, M. R., Reisz-Porszasz, S., and Hankinson, O. (1995). Identification of functional domains of the aryl hydrocarbon receptor. J. Biol. Chem. 270, 29270-29278.
27. Fukunaga, B. N., and Hankinson, O. (1996). Identification of a novel domain in the aryl hydrocarbon receptor required for DNA binding. J. Biol. Chem. 271, 3743-3749.
28. Gaido, K. W., Maness, S. C., Leonard, L. S., and Greenlee, W. F. (1992). 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent regulation of transforming growth factors-alpha and -beta 2 expression in a human keratinocyte cell line involves both transcriptional and post-transcriptional control. J. Biol. Chem. 267, 24591-24595.
29. Geiger, L. E., and Neal, R. A. (1981). Mutagenicity testing of 2,3,7,8-tetrachlorodibenzo-p-dioxin in histidine auxotrophs of Salmonella typhimurium. Toxicol. Appl. Pharmacol. 59, 125-129.
30. Graham, F. L., and Van der Erb, A. J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
31. Greenlee, W. F., and Neal, R. A. (1985). The Ah receptor: A biochemical and biological perspective. The Receptors, Vol. 2 (Conn, P. M. Ed.), pp. 89-129, Academic Press, New York.
32. Gutman, A., Wasylyk, C., and Wasylyk, B. (1991). Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter. Mol. Cell. Biol. 11, 5381-5387.
33. Hankinson, O. (1993). Research on the aryl hydrocarbon (Dioxin) receptor is primed to take off. Arch. Biochem. Biophys. 300, 1-5.
34. Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340.
35. Jensen, F. C., Girardi, A. J., Gilden, R. V., and Koprowski, H. (1964). Infection of human and simian tissue cultures with Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 52, 53-59.
36. Karenlampi, S. O., Eisen, H. J., Hankinson, O., and Nebert, D. W. (1983). Effects of cytochrome P1-450 inducers on the cell-surface receptors for epidermal growth factor, phorbol 12,13-dibutyrate, or insulin of cultured mouse hepatoma cells. J. Biol. Chem. 258, 10378-10383.
37. Karin, M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486.
38. Kawamoto, T., Matsumura, F., Madhukar, B. V., and Bombick, D. W. (1989). Effects of TCDD on the EGF receptor of XB mouse keratinizing epithelial cells. J. Biochem. Toxicol. 4, 173-182.
39. Knutson, J. C., and Poland, A. (1982). Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-p-dioxin: Interaction of the Ah and hr loci. Cell 30, 225-234.
40. Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D. A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S. D., Hummel, R. A., and Humiston, C. G. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.
41. Landers, J. P., and Bunce, N. J. (1991). The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 276, 273-287.
42. 2 are localized to the TATA box binding region and controlled through a tyrosine kinase-dependent pathway. Toxicol. Appl. Pharmacol. 137, 90-99.
43. Lin, F. H., Clark, G., Birnbaum, L. S., Lucier, G. W., and Goldstein, J. A. (1991). Influence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic epidermal growth factor receptor. Mol. Pharmacol. 39, 307-313.
44. Ma, X., Mufti, N. A., and Babish, J. G. (1992). Protein tyrosine phosphorylation as an indicator of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure in vivo and in vitro. Biochem. Biophys. Res. Commun. 189, 59-65.
45. Ma, X., and Babish, J. G. (1993). Acute 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure results in enhanced tyrosylphosphorylation and expression of murine hepatic cyclin dependent kinases. Biochem. Biophys. Res. Commun. 197, 1070-1077.
46. Madhukar, B. V., Brewster, D. W., and Matsumura, F. (1984). Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamster. Proc. Natl. Acad. Sci. USA 81, 7407-7411.
47. Manz, A., Berger, J., Dwyer, J. H., Flesch-Janys, D., Nagel, S., and Waltsgott, H. (1991). Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet 338, 959-964.
48. Matsumura, F., Brewster, D. W., Madhukar, B. V., and Bombick, D. W. (1984). Alteration of rat hepatic plasma membrane functions by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Arch. Environ. Contam. Toxicol. 13, 509-515.
49. Matsushita, N., Sogawa, K., Ema, M., Yoshida, A., and Fujii-Kuriyama, Y. (1993). A factor binding to the xenobiotic responsive element (XRE) of P-4501a1 gene consists of at least two helix-loop-helix proteins, Ah receptor and arnt. J. Biol. Chem. 268, 21002-21006.
50. Neal, R. A., Olson, J. R., Gasiewicz, T. A., and Geiger, L. E. (1982). The toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mammalian systems. Drug Metab. Rev. 13, 355-385.
51. Nebert, D. W. (1989). The Ah locus: Genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20, 153-174.
52. 1450 (Cyp1a1) gene. Int. J. Biochem. 21, 243-252.
53. Nebert, D. W., Puga, A., and Vasiliou, V. (1993). Role of the Ah receptor and dioxin inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann. N. Y. Acad. Sci. 685, 624-640.
54. Nebert, D. W., and Gelboin, H. V. (1968). Substrate-inducible microsomal aryl hydrocarbon hydroxylase in mammalian cell culture. I. Assay and properties of the induced enzyme. J. Biol. Chem. 243, 6242-6249.
55. Poland, A., Palen, D., and Glover, E. (1982). Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature 300, 271-273.
56. Poland, A., and Glover, E. (1979). An estimate of the maximum in vivo covalent binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin to rat liver protein, ribosomal RNA, and DNA. Cancer Res. 39, 3341-3344.
57. Poland, A., and Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanisms of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554.
58. Puga, A., RayChaudhuri, B., Salata, K., Zhang, Y.-H., and Nebert, D. W. (1990). Stable expression of mouse Cyp1a-1 and human CYP1A-2 cDNAs transfected into mouse hepatoma cells lacking detectable P450 enzyme activity. DNA Cell Biol. 9, 425-436.
59. Puga, A., Nebert, D. W., and Carrier, F. (1992). Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11, 269-281.
60. Radler-Pohl, A., Sachsenmaier, C., Gebel, S., Auer, H. P., Bruder, J. T., Rapp, U., Angel, P., Rahmsdorf, H. J., and Herrlich, P. (1993). UV-induced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J. 12, 1005-1012.
61. Sachsenmaier, C., Radler-Pohl, A., Zinck, R., Nordheim, A., Herrlich, P., and Rahmsdorf, H. J. (1994). Involvement of growth factor receptors in the mammalian UVC response. Cell 78, 963-972.
62. Schüller, H. M. (1991). The signal transduction model of carcinogenesis. Biochem. Pharmacol. 42, 1511-1523.
63. Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., and Karin, M. (1991). Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. Nature 354, 494-496.
64. Suskind, R. R. (1985). Chloracne, the hallmark of dioxin intoxication. Scand. J. Work Environ. Health 11, 165-171.
65. Sutler, T. R., Guzman, K., Dold, K. M., and Greenlee, W. F. (1991). Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science 254, 415-418.
66. Swanson, H. I., and Bradfield, C. A. (1993). The AH-receptor: Genetics, structure and function. Pharmacogenetics 3, 213-230.
67. Tullis, K., Olsen, H., Bombick, D. W., Matsumura, F., and Jankun, J. (1992). TCDD causes stimulation of c-ras expression in the hepatic plasma membranes in vivo and in vitro. J. Biochem. Toxicol. 7, 107-116.
68. van Dam, H., Duyndam, M., Rottier, R., Bosch, A., de Vries-Smits, L., Herrlich, P., Zantema, A., Angel, P., and van der Eb, A. J. (1993). Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12, 479-487.
69. van Dam, H., Wilhelm, D., Herr, I., Steffen, A., Herrlich, P., and Angel, P. (1995). ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14, 1798-1811.
70. van den Berg, S., Kaina, B., Rahmsdorf, H. J., Ponta, H., and Herrlich, P. (1991). Involvement of fos in spontaneous and ultraviolet light-induced genetic changes. Mol. Carcinogen. 4, 460-466.
71. Wassom, J. S., Huff, J. E., and Loprieno, N. (1977). A review of the genetic toxicology of chlorinated dibenzo-p-dioxins. Mutat. Res. 47, 141-160.
72. Westwick, J. K., Cox, A. D., Der, C. J., Cobb, M. H., Hibi, M., Karin, M., and Brenner, D. A. (1994). Oncogenic Ras activates c-Jun via a separate pathway from the activation of extracellular signal-regulated kinases. Proc. Natl. Acad. Sci. USA 91, 6030-6034.
73. Whitlock, J. P., Jr. (1993). Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6, 754-763.
74. Wu, L., and Whitlock, J. P., Jr. (1993). Mechanism of dioxin action: Receptor - enhancer interactions in intact cells. Nucleic Acids Res. 21, 119-125.
75. Zugerman, C. (1990). Chloracne. Clinical manifestations and etiology. Dermatol. Clin. 8, 209-213.